These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5897137)

  • 21. [Rigevidon and Ovidon in the therapy of menstrual cycle disorders].
    Prilepskaia VN; Baklaenko NG; Chernaia VV
    Akush Ginekol (Mosk); 1983 Nov; (11):24-7. PubMed ID: 6666792
    [No Abstract]   [Full Text] [Related]  

  • 22. [Sequential therapeutics in gynecology. (Apropos of 40 cases)].
    Gelle P; Vitse M; Duthoit F; Silberberg L; Lescut JC
    Lille Med; 1968 Apr; 13(4):Suppl:511-4. PubMed ID: 4176311
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of menstruation anomalies and preclimacteric disturbances by Duoluton].
    Tscherne E
    Ther Ggw; 1970 Jan; 109(1):93-4 passim. PubMed ID: 5437260
    [No Abstract]   [Full Text] [Related]  

  • 24. [Use of a synthetic estro-progestational hormone: C. S. 1516 in gynecologic therapeutics. Apropos of 39 cases].
    Guilhem P; Pontonnier A; Monrozies M; Pontonnier G; Bardenat M
    Bull Fed Soc Gynecol Obstet Lang Fr; 1966; 18(3):327-33. PubMed ID: 4164208
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical experiences with a new anabolic steroid, 19-nortestosterone furylpropionate in the treatment of immature and mature babies.
    Saito M; Sugata K; Ishida M
    Bull Tokyo Med Dent Univ; 1965 Dec; 12(4):343-54. PubMed ID: 5217381
    [No Abstract]   [Full Text] [Related]  

  • 26. Anabolic steroid boosts weight.
    GMHC Treat Issues; 1996 Sep; 10(9):8-9. PubMed ID: 11363845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On the use of ethinyl-nortestosterone acetate].
    HERRMANN U; BERGEMANN E; ARNOLD M
    Gynaecologia; 1959 Nov; 148():334-40. PubMed ID: 14401378
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clogestone acetate, a new orally effective progestagen].
    Hinselmann M; Jürgensen O; Hasselblatt I; Otten U; Prinz W; Taubert HD
    Arch Gynakol; 1970 Aug; 209(2):136-48. PubMed ID: 5537778
    [No Abstract]   [Full Text] [Related]  

  • 29. [Estrogen-free treatment of prolonged hemorrhages caused by cyclic function disorders with small doses of primolut-N and ethinyl-nortestosterone acetate].
    WASCHKE G
    Zentralbl Gynakol; 1960 Nov; 82():1721-32. PubMed ID: 13783277
    [No Abstract]   [Full Text] [Related]  

  • 30. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Use of the preparation dl-13-ethyl-17-alpha-ethinyl-17-beta-hydroxy-4-gonen-3-on (WY 3707) in combination with ethinyl estradiol in gynecologic treatment and contraception].
    Misinger I; Krobová I; Moravcová V
    Cesk Gynekol; 1968 Jun; 33(5):329-32. PubMed ID: 5662271
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial.
    Fraser IS; Römer T; Parke S; Zeun S; Mellinger U; Machlitt A; Jensen JT
    Hum Reprod; 2011 Oct; 26(10):2698-708. PubMed ID: 21784734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Exfoliative cytology of the oral mucosa during treatment with 4-hydroxy-17-alpha-methyl-19-nortestosterone].
    Nicolin LT
    Ann Stomatol (Roma); 1967 Oct; 16(10):833-50. PubMed ID: 5237155
    [No Abstract]   [Full Text] [Related]  

  • 34. [Description of a new method of ovarian inhibition: the "sequential method". Results of its use in the treatment of dysmenorrheas and inter-menstrual disorders. (Study of 172 subjects treated during 573 cycles)].
    Gueguen J
    Rev Fr Gynecol Obstet; 1967 Jun; 62(6):279-86. PubMed ID: 4193181
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of the action on pregnancy of the rat of 17-ethinyl 19-nortestosterone, of 17-methyl 19-nortestosterone and 17-ethinyl testosterone].
    MAROIS M
    Bull Acad Natl Med; 1960 Jun 5-Jul 28; 144():511-8. PubMed ID: 14421389
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of an antiandrogen, 17-alpha-methyl-B-nortestosterone, on acne and hirsutism.
    Zarate A; Mahesh VB; Greenblatt RB
    J Clin Endocrinol Metab; 1966 Dec; 26(12):1394-8. PubMed ID: 4225258
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of biphasic cyclic hormone therapy in functional bleeding disorders of adolescents (Anteovin).
    Kis-Csitári I
    Ther Hung; 1988; 36(2):73-6. PubMed ID: 3201389
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical and biochemical effects of megestrol acetate allone and two megestrol acetate-estrogen combinations in gynecological indications].
    Arnold M; Richter RH; Roth F
    Z Geburtshilfe Gynakol; 1969 Oct; 171(2):125-44. PubMed ID: 5355553
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M; Corette L; Coliche D
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):434. PubMed ID: 5153231
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences with the oral contraceptive Anovlar].
    Rice-Wray E; Corren S; Gastelum H
    Med Klin; 1966 Jun; 61(24):959-64. PubMed ID: 5993437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.